| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4dae7331034b6b26116b7c2f7acb115 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-804
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2730-10122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-82 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-0082
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-082
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-576
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L2-00 |
| filingDate |
1972-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1975-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f12781ba3d825b4b3329f7430fc8dcae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4f98c90b1f5d7a88ac8ba42615c1a5d |
| publicationDate |
1975-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-3896218-A |
| titleOfInvention |
Radiommunoassay determining the hepatitis associated antigen content of blood |
| abstract |
Antibodies to serum hepatitis are coupled to carbohydrate macro particles which are then contacted with blood fluids, suitably plasma, which are believed to contain serum hepatitis antigen. The serum hepatitis antigen is thus complexed with the bound antibody and the particles bearing both the antibody and the antigen are removed from the blood fluid. The antigen is then cleaved from the antibody by alkaline treatment, and may, if desired, be itself isolated, suitably by dialysis. The antibody/agarose complex is then available for recycling in a further batch of contaminated blood fluids. There is also disclosed a novel method of highly sensitive measurement of the extent of contamination of blood fluids with serum hepatitis antigen. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4642285-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4474878-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE32696-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100421763-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4038378-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4292296-A |
| priorityDate |
1972-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |